Literature DB >> 19892702

Co-chaperone CHIP stabilizes aggregate-prone malin, a ubiquitin ligase mutated in Lafora disease.

Sudheendra N R Rao1, Jaiprakash Sharma, Ranjan Maity, Nihar Ranjan Jana.   

Abstract

Lafora disease (LD) is an autosomal recessive neurodegenerative disorder caused by mutation in either the dual specificity phosphatase laforin or ubiquitin ligase malin. A pathological hallmark of LD is the accumulation of cytoplasmic polyglucosan inclusions commonly known as Lafora bodies in both neuronal and non-neuronal tissues. How mutations in these two proteins cause disease pathogenesis is not well understood. Malin interacts with laforin and recruits to aggresomes upon proteasome inhibition and was shown to degrade misfolded proteins. Here we report that malin is spontaneously misfolded and tends to be aggregated, degraded by proteasomes, and forms not only aggresomes but also other cytoplasmic and nuclear aggregates in all transfected cells upon proteasomal inhibition. Malin also interacts with Hsp70. Several disease-causing mutants of malin are comparatively more unstable than wild type and form aggregates in most transfected cells even without the inhibition of proteasome function. These cytoplasmic and nuclear aggregates are immunoreactive to ubiquitin and 20 S proteasome. Interestingly, progressive proteasomal dysfunction and cell death is also most frequently observed in the mutant malin-overexpressed cells compared with the wild-type counterpart. Finally, we demonstrate that the co-chaperone carboxyl terminus of the Hsc70-interacting protein (CHIP) stabilizes malin by modulating the activity of Hsp70. All together, our results suggest that malin is unstable, and the aggregate-prone protein and co-chaperone CHIP can modulate its stability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892702      PMCID: PMC2801266          DOI: 10.1074/jbc.M109.006312

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

Review 2.  Advances in lafora progressive myoclonus epilepsy.

Authors:  Antonio V Delgado-Escueta
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

3.  AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex.

Authors:  Santiago Vernia; M Carmen Solaz-Fuster; José Vicente Gimeno-Alcañiz; Teresa Rubio; Luisa García-Haro; Marc Foretz; Santiago Rodríguez de Córdoba; Pascual Sanz
Journal:  J Biol Chem       Date:  2009-01-26       Impact factor: 5.157

4.  Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy.

Authors:  David Vilchez; Susana Ros; Daniel Cifuentes; Lluís Pujadas; Jordi Vallès; Belén García-Fojeda; Olga Criado-García; Elena Fernández-Sánchez; Iria Medraño-Fernández; Jorge Domínguez; Mar García-Rocha; Eduardo Soriano; Santiago Rodríguez de Córdoba; Joan J Guinovart
Journal:  Nat Neurosci       Date:  2007-10-21       Impact factor: 24.884

5.  Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG).

Authors:  Carolyn A Worby; Matthew S Gentry; Jack E Dixon
Journal:  J Biol Chem       Date:  2007-12-10       Impact factor: 5.157

6.  Deletions and missense mutations of EPM2A exacerbate unfolded protein response and apoptosis of neuronal cells induced by endoplasm reticulum stress.

Authors:  Yan Liu; Yin Wang; Cindy Wu; Yang Liu; Pan Zheng
Journal:  Hum Mol Genet       Date:  2009-04-29       Impact factor: 6.150

7.  Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.

Authors:  Maria Carmen Solaz-Fuster; José Vicente Gimeno-Alcañiz; Susana Ros; Maria Elena Fernandez-Sanchez; Belen Garcia-Fojeda; Olga Criado Garcia; David Vilchez; Jorge Dominguez; Mar Garcia-Rocha; Maribel Sanchez-Piris; Carmen Aguado; Erwin Knecht; Jose Serratosa; Joan Josep Guinovart; Pascual Sanz; Santiago Rodriguez de Córdoba
Journal:  Hum Mol Genet       Date:  2007-11-20       Impact factor: 6.150

Review 8.  Lafora progressive myoclonus epilepsy: a meta-analysis of reported mutations in the first decade following the discovery of the EPM2A and NHLRC1 genes.

Authors:  Shweta Singh; Subramaniam Ganesh
Journal:  Hum Mutat       Date:  2009-05       Impact factor: 4.878

9.  The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system.

Authors:  Punitee Garyali; Pratibha Siwach; Pankaj Kumar Singh; Rajat Puri; Shuchi Mittal; Sonali Sengupta; Rashmi Parihar; Subramaniam Ganesh
Journal:  Hum Mol Genet       Date:  2008-11-25       Impact factor: 6.150

10.  A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease.

Authors:  Alan Cheng; Mei Zhang; Matthew S Gentry; Carolyn A Worby; Jack E Dixon; Alan R Saltiel
Journal:  Genes Dev       Date:  2007-10-01       Impact factor: 11.361

View more
  22 in total

Review 1.  Laforin, a protein with many faces: glucan phosphatase, adapter protein, et alii.

Authors:  Matthew S Gentry; Carlos Romá-Mateo; Pascual Sanz
Journal:  FEBS J       Date:  2012-03-16       Impact factor: 5.542

Review 2.  Deciphering the role of malin in the lafora progressive myoclonus epilepsy.

Authors:  Carlos Romá-Mateo; Pascual Sanz; Matthew S Gentry
Journal:  IUBMB Life       Date:  2012-07-20       Impact factor: 3.885

3.  Environmental Enrichment Improves Behavioral Abnormalities in a Mouse Model of Angelman Syndrome.

Authors:  Imran Jamal; Vipendra Kumar; Naman Vatsa; Brijesh Kumar Singh; Shashi Shekhar; Ankit Sharma; Nihar Ranjan Jana
Journal:  Mol Neurobiol       Date:  2016-09-01       Impact factor: 5.590

Review 4.  Lafora disease: from genotype to phenotype.

Authors:  Rashmi Parihar; Anupama Rai; Subramaniam Ganesh
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 5.  The E3 ubiquitin ligase CHIP in normal cell function and in disease conditions.

Authors:  Tingyu Wang; Wenbo Wang; Qishan Wang; Rong Xie; Alan Landay; Di Chen
Journal:  Ann N Y Acad Sci       Date:  2019-08-15       Impact factor: 5.691

6.  Dysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington disease.

Authors:  Megha Maheshwari; Ananya Samanta; Swetha K Godavarthi; Rajarshi Mukherjee; Nihar Ranjan Jana
Journal:  J Biol Chem       Date:  2012-07-11       Impact factor: 5.157

7.  Malin regulates Wnt signaling pathway through degradation of dishevelled2.

Authors:  Jaiprakash Sharma; Shalaka Mulherkar; Diptendu Mukherjee; Nihar Ranjan Jana
Journal:  J Biol Chem       Date:  2012-01-05       Impact factor: 5.157

8.  Serine/threonine protein phosphatase 5 (PP5) interacts with substrate under heat stress conditions and forms protein complex in Arabidopsis.

Authors:  Jin Ho Park; Woe Yeon Kim; Ho Byoung Chae; Min Gab Kim; Sang Yeol Lee
Journal:  Plant Signal Behav       Date:  2012-04-20

9.  The laforin-malin complex, involved in Lafora disease, promotes the incorporation of K63-linked ubiquitin chains into AMP-activated protein kinase beta subunits.

Authors:  Daniel Moreno; Mhairi C Towler; D Grahame Hardie; Erwin Knecht; Pascual Sanz
Journal:  Mol Biol Cell       Date:  2010-06-09       Impact factor: 4.138

10.  Neuronatin-mediated aberrant calcium signaling and endoplasmic reticulum stress underlie neuropathology in Lafora disease.

Authors:  Jaiprakash Sharma; Diptendu Mukherjee; Sudheendra N R Rao; Soumya Iyengar; Susarla Krishna Shankar; Parthasarathy Satishchandra; Nihar Ranjan Jana
Journal:  J Biol Chem       Date:  2013-02-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.